ANI Pharmaceuticals (ANIP) vs COMPASS Pathways Plc American Depository Shares (CMPS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
COMPASS Pathways Plc American Depository Shares (CMPS) has outperformed ANI Pharmaceuticals (ANIP) over the past year, gaining 87.3% versus a loss of 21.5%. Over five years, ANIP leads with a +86.6% price change compared with -63.7% for CMPS. ANI Pharmaceuticals is the larger company by market cap ($1.65 billion vs $1.59 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANIP | CMPS |
|---|---|---|
| Share price | $71.98 | $11.47 |
| Market cap | $1.65B | $1.59B |
| 1-day change | +0.07% | -1.88% |
| YTD return | -8.88% | +69.42% |
| 1-year return | -21.54% | +87.34% |
| 5-year return | +86.64% | -63.72% |
| P/E ratio (TTM) | 15.58 | — |
| Forward P/E | 7.08 | — |
| EPS (TTM) | $4.62 | $-3.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $97.00 | $15.87 |
| 52-week low | $69.58 | $4.88 |
| Distance from 52-week high | -25.79% | -27.73% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +46.96% | +107.06% |
| Average volume | 372.56K | 3.04M |
| Shares outstanding | 22.96M | 138.48M |
| Employees | 970 | 156 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CMPS has outperformed ANIP by 108.9 percentage points over the past year.
About ANI Pharmaceuticals
ANIP stock →ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
Health Care · Biotechnology: Pharmaceutical Preparations · 970 employees
About COMPASS Pathways Plc American Depository Shares
CMPS stock →COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa.
Health Care · Biotechnology: Pharmaceutical Preparations · 156 employees
ANIP vs CMPS FAQ
Which is bigger, ANI Pharmaceuticals or COMPASS Pathways Plc American Depository Shares?
ANI Pharmaceuticals (ANIP) is larger, with a market capitalization of $1.65B compared with $1.59B for COMPASS Pathways Plc American Depository Shares (CMPS).
Which stock has performed better over the past year, ANIP or CMPS?
CMPS returned +87.34% over the past 12 months, compared with -21.54% for ANIP (price return, excluding dividends). Past performance does not predict future results.
Are ANI Pharmaceuticals and COMPASS Pathways Plc American Depository Shares in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.